STOMACH NEOPLASMS
Clinical trials for STOMACH NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new STOMACH NEOPLASMS trials appear
Sign up with your email to follow new studies for STOMACH NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists map family trees of stomach cancer to unlock genetic secrets
Knowledge-focused CompletedThis study aimed to better understand rare forms of stomach cancer that run in families. Researchers gathered health information and genetic samples from 733 people with a personal or family history of these cancers. The goal was to learn how specific gene changes lead to disease…
Matched conditions: STOMACH NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:25 UTC
-
A phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric orgastroesophageal junction adenocarcinoma (KEYNOTE-859)
CompletedThe purpose of this study is to evaluate the efficacy of pembrolizumab (MK-3745) in combination with chemotherapy (Cisplatin combined with 5-Fluorouracil \[FP regimen\] or oxaliplatin combined with capecitabine \[CAPOX regimen\]) versus placebo in combination with chemotherapy (F…
Matched conditions: STOMACH NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC
Last updated Mar 02, 2026 15:22 UTC